Nav

Classification of Meningiomas

Request a Second Opinion

If you or a loved one has recently been diagnosed with a meningioma, it is common to have a lot of questions regarding the diagnosis. Meningiomas are the most common brain tumor, accounting for over one third of all intracranial tumors diagnosed in the United States in recent years.

The World Health Organization (WHO) classification system for meningiomas delineates between Grade I, Grade II, and Grade III meningiomas. This delineation is based on the pathology of the tumor (how the cells look under a microscope) and can be used to predict disease progression and therefore survival/prognosis.

Healthcare professionals often use the WHO classification system when discussing the diagnosis of a meningioma with patients. This article will attempt to answer the commonly asked questions about meningioma grading system, allowing you to make informed care decisions.

What Is a WHO Grade I Meningioma?

WHO Grade I meningiomas are benign tumors with the following cell types:

  • meningothelial
  • fibrous (fibroblastic)
  • transitional (mixed)
  • psammomatous
  • angiomatous
  • microcystic
  • secretory
  • lymphoplasmacyte-rich
  • metaplastic

These benign tumors grow at a slower rate, are less likely to invade adjacent brain tissue or spread to other locations throughout the body (i.e., metastasize), and generally have a more favorable prognosis. Grade I meningiomas are less likely to recur after tumor resection.

Why should you have your surgery with Dr. Cohen?

Dr. Cohen

  • 7,500+ specialized surgeries performed by your chosen surgeon
  • More personalized care
  • Extensive experience = higher success rate and quicker recovery times

Major Health Centers

  • No control over choosing the surgeon caring for you
  • One-size-fits-all care
  • Less specialization

For more reasons, please click here.

What Is a WHO Grade II Meningioma?

WHO Grade II meningiomas are atypical tumors with the following cell types:

  • chordoid
  • clear cell
  • atypical

According to the WHO classification system, meningiomas are characterized on a spectrum that ranges from benign (Grade I) to malignant (Grade III). The grade II or atypical tumors have characteristics that fall in between benign and malignant behaviors. For example, atypical meningiomas grow faster than benign meningiomas, but not as fast as malignant meningiomas. You might hear meningiomas being talked about in the frame of malignant vs non-malignant; in this scenario, both WHO Grade I and WHO Grade II meningiomas are considered non-malignant. 

What Is a WHO Grade III Meningioma?

WHO Grade III meningiomas are considered malignant tumors with the following cell types:

  • papillary
  • rhabdoid
  • anaplastic

These malignant tumors grow more rapidly, are more likely to invade adjacent brain tissue or spread to other locations throughout the body, and do not have as favorable of a prognosis as benign tumors. Grade III meningiomas are more likely to grow back after initial tumor resection.


                                    
                                        Figure 1. Example of a right parieto-occipital meningioma on a variety of MRI sequences.

Figure 1. Example of a right parieto-occipital meningioma on a variety of MRI sequences.

Key Takeaways

The WHO classification system of meningiomas is commonly used during discussions with patients and caregivers. The grade of a meningioma is significant in terms of disease progression and prognosis. Grade I and Grade II meningiomas are non-malignant and are the majority of meningiomas encountered. These non-malignant tumors typically have better outcomes than Grade III (malignant) meningiomas. It is important to be aware of these differences, as this information may guide treatment options including radiation treatment after surgical resection.

Resources

Real Patient Stories

Dr. Cohen is the best of the best of the best. I had a large tumor (42.85mm x 37.79mm) pressing against my brain. I was referred to Dr. Cohen, who reviewed my scans and gave me the peace of mind...

Show Full Review

Ramon A.

Dr. Cohen gave me my life back. It’s cliché, but the truest explanation of the amazing work he and his entire team did for me. He performed a very tricky Microvascular decompression of my...

Show Full Review

Michael S.

Dr. Cohen took care of my son who had an AVM (Arteriovenous Malformation). Dr. Cohen recommended surgical removal, which was not what neurosurgeons we had seen before recommended. It was a...

Show Full Review

Lisa S.

One of the Most Prominent Neurosurgeons in the World

Aaron Cohen-Gadol, MD

7,500+

Complex brain surgeries performed by a single surgeon—more than any other neurosurgeon in the United States.

40+

Novel surgical techniques pioneered that have inspired thousands of neurosurgeons to achieve technical excellence.

600+

Peer-reviewed publications in respected journals advancing the field of neurosurgery and patient outcomes.

100,000+

Lives influenced through innovative surgical care, education, and his foundational contributions to the field.

Meet Dr. Cohen-Gadol

Dr. Cohen-Gadol (Cohen) is one of the world’s most preeminent neurosurgeons and the president of ATLAS Institute of Brain and Spine. He specializes in the treatment of complex brain and spine tumors, including meningiomas, pituitary adenomas, gliomas, and acoustic neuromas, as well as arteriovenous and cavernous malformations, hemifacial spasm, and trigeminal neuralgia. Neurosurgeons and patients both frequently seek his expert second opinion. Throughout his career, he has demonstrated a profound commitment and passion for pushing the boundaries of uncompromising excellence for his patients.

Professional Affiliations

Address

8631 W. 3rd Street, Suite 815E
Los Angeles, CA 90048

Opening Hours

Mon - Fri, 9:00 a.m. - 5:00 p.m

In Person Second Opinion Virtual Call

Copyright © 2025 Aaron Cohen-Gadol. All Rights Reserved.